Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 4, 2008 - Issue 4
Submit an article Journal homepage
83
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder

Walter Deberdt1 Eli Lilly Benelux, Eli Lilly and Company, Brussels, BelgiumCorrespondence[email protected]
,
Ilya Lipkovich2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Alexandra N Heinloth3 i3Statprobe, Ingenix, Cary, NC, USA
,
Lin Liu2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Sara Kollack-Walker2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Sara E Edwards2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
,
Vicki Poole Hoffmann2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
&
Thomas A Hardy2 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
 show all
Pages 713-720 | Published online: 08 Aug 2008

References

  • Ascher-SvanumHZhuBFariesD2006Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophreniaBMC Psychiatry6816504026
  • BaptistaTRangelNFernandezV2007Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trialSchizophr Res939910817490862
  • BeasleyCMJrStaufferVLLiu-SeifertH2007All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysisJ Clin Psychopharmacol27252817502771
  • CramerJARosenheckR1998Compliance with medication regimens for mental and physical disordersPsychiatr Serv491962019575004
  • DeberdtWWinokurACavazzoniPA2005Amantadine for weight gain associated with olanzapine treatmentEur Neuropsychopharmacol15132115572269
  • EssockSMCovellNHDavisSM2006Effectiveness of switching antipsychotic medicationsAm J Psychiatry1632090517151159
  • GarmanPMRiedLDBengtsonMA2007Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophreniaJ Am Pharm Assoc (Wash)473738
  • GuptaSMasandPSVirkS2004Weight decline in patients switching from olanzapine to quetiapineSchizophr Res70576215246464
  • GuyW1976ECDEU Assessment manual for Psychopharmacology, Revised (Publication ADM 76-338). US Dept of Health, Education, and Welfare.
  • KaySRFiszbeinAOplerLA1987The positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull13261763616518
  • KinonBJKaiserCJAhmedS2005Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disordersJ Clin Psychopharmacol25255815876905
  • Liu-SeifertHAdamsDHKinonBJ2005Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugsBMC Med32116375765
  • MallinckrodtCHSangerTMDubeS2003Assessing and interpreting treatment effects in longitudinal clinical trials with missing dataBiol Psychiatry537546012706959
  • MontesJMRodriguezJLBalboE2007Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidoneProg Neuropsychopharmacol Biol Psychiatry31383817129654
  • PerkinsDOGuHWeidenPJ2007Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, of schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter studyJ Clin Psychiatrye1e8[Epub ahead of print].
  • StroupTSLiebermanJAMcEvoyJP2006Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychoticAm J Psychiatry1636112216585435
  • WeidenPJKozmaCGroggA2004Partial compliance and risk of rehospitalization among California Medicaid patients with schizophreniaPsychiatr Serv558869115292538

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.